NCT02240056

Brief Summary

Certain cardiac and neurologic diseases influence each other via a still poorly understood "brain-heart axis". Subarachnoidal bleedings are well known to cause ECG alterations resembling those of myocardial infarction, along with a reduction of systolic myocardial function ("neurogenic stunned myocardium"). Alterations of the right insula region by a stroke or intracranial hemorrhage go along with a sympathetic activation (increased circulating catecholamine levels, tachycardia, arterial hypertension). In contrast, alterations of the left insula region often cause vagal reactions such as bradycardia, arterial hypotension. Takotsubo cardiomyopathy (TTC) is a just recently recognised subform of heart attacks, often caused by psychological or physical stress (death of a beloved one, divorce, job loss, infection, preoperative state). In more than 90% of cases, TTC affects postmenopausal women. Functional MRT enables imaging of activated brain regions, either without ("resting state") or with specific stimuli. The investigators speculate that there is a specific involvement of the insula region during TTC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 15, 2014

Completed
16 days until next milestone

Study Start

First participant enrolled

October 1, 2014

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

March 7, 2019

Status Verified

March 1, 2019

Enrollment Period

4.2 years

First QC Date

September 11, 2014

Last Update Submit

March 5, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in brain functional MRT (resting state, paradigma) in postmenopausal females suffering from TTC as compared to NSTEMI / STEMI postmenopausal female patients

    Within the first 72h after diagnosis and after 4-8 weeks

Study Arms (3)

TTC

postmenopausal women with acute Takotsubo cardiomyopathy (TTC), diagnosis by coronary angiography within 24 hours of symptom onset

NSTEMI / STEMI

postmenopausal women with acute ST elevation myocardial infarction (NSTEMI / STEMI), diagnosis by coronary angiography within 24 hours of symptom onset

healthy subjects

healthy postmenopausal women without coronary artery disease

Eligibility Criteria

AgeUp to 90 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Postmenopausal women with TTC or NSTEMI / STEMI aged below 90 years

You may qualify if:

  • Postmenopausal females aged below 90 years
  • Informed written consent
  • TTC or NSTEMI / STEMI undergoing coronary angiography within 24 hours of symptom onset

You may not qualify if:

  • Delayed coronary angiography (\> 24 hours after symptom onset)
  • Inability to perform rsfMRT within the first 72 hours after coronary angiography
  • Inability to communicate in German language
  • Contraindications for a MRT examination (including pacemaker, implantable cardioverter-defibrillator, mechanical heart valves, claustrophobia, severe adipositas)
  • Drug addiction, under guardianship
  • Inability to stick to the follow up examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University Innsbruck

Innsbruck, Tyrol, 6020, Austria

Location

MeSH Terms

Conditions

Takotsubo Cardiomyopathy

Condition Hierarchy (Ancestors)

CardiomyopathiesHeart DiseasesCardiovascular DiseasesVentricular Dysfunction, LeftVentricular Dysfunction

Study Officials

  • Wolfgang Dichtl, MD PhD

    Medical University Innsbruck

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Priv.Doz. DDr.

Study Record Dates

First Submitted

September 11, 2014

First Posted

September 15, 2014

Study Start

October 1, 2014

Primary Completion

December 1, 2018

Study Completion

March 1, 2019

Last Updated

March 7, 2019

Record last verified: 2019-03

Locations